| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Product containing haloperidol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Haloperidol measurement |
Component |
True |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Accidental haloperidol poisoning |
Causative agent (attribute) |
False |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Intentional haloperidol poisoning |
Causative agent (attribute) |
False |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| intoxication par l'halopéridol d'intention indéterminée |
Causative agent (attribute) |
False |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Haloperidol adverse reaction |
Causative agent (attribute) |
True |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Haloperidol allergy |
Causative agent (attribute) |
False |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Haloperidol overdose |
Causative agent (attribute) |
True |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Accidental haloperidol overdose |
Causative agent (attribute) |
True |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Intentional haloperidol overdose |
Causative agent (attribute) |
True |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| surdose d'halopéridol d'intention indéterminée |
Causative agent (attribute) |
False |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Haloperidol [antipsychotic] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Haloperidol 1.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely haloperidol 5 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Haloperidol 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Haloperidol 20 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely haloperidol 2 milligram/1 milliliter conventional release oral solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Haloperidol 2mg/5mL s/f oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Haloperidol 1mg/5mL s/f oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely haloperidol 500 microgram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Haloperidol 1 mg/mL oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Haloperidol 20mg/2mL injection (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Haloperidol 1.5mg/5mL s/f oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| décanoate d'halopéridol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Haloperidol [tics, chorea] [see D47..] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing haloperidol in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing haloperidol in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Haloperidol 1 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Haloperidol decanoate 50mg/mL injection (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Haloperidol 0.5mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Haloperidol 2 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Haloperidol 100mg injection solution ampoule (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Haloperidol 5mg injection solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Oral haloperidol solution (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Poisoning by haloperidol |
Causative agent (attribute) |
True |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Haloperidol 500 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Haloperidol decanoate (substance) |
Is a |
False |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Haloperidol lactate (substance) |
Is a |
False |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| halopéridol 5 mg/1 mL, pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| halopéridol 50 mg/1 mL, injection huileuse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| halopéridol 100 mg/1 mL, injection huileuse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Intentional haloperidol poisoning |
Causative agent (attribute) |
True |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Accidental poisoning caused by haloperidol (disorder) |
Causative agent (attribute) |
True |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Haloperidol 100mg injection solution ampoule (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Haloperidol allergy |
Causative agent (attribute) |
True |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Haloperidol 1.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Haloperidol 1.5 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely haloperidol 5 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely haloperidol 5 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Haloperidol 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Haloperidol 10 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Haloperidol 20 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Haloperidol 20 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely haloperidol 500 microgram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely haloperidol 500 microgram/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Haloperidol 500 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Haloperidol 500 microgram oral tablet |
Has basis of strength substance (attribute) |
True |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Haloperidol 1 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Haloperidol 1 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Haloperidol 2 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Haloperidol 2 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Haloperidol decanoate (substance) |
Is modification of (attribute) |
True |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Haloperidol lactate (substance) |
Is modification of (attribute) |
True |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Haloperidol 300 microgram/mL oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Haloperidol 200 microgram/mL oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely haloperidol 400 microgram/1 milliliter conventional release oral solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely haloperidol 500 microgram/1 each conventional release oral capsule (clinical drug) |
Has precise active ingredient |
True |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Haloperidol 500 microgram oral tablet |
Has precise active ingredient |
True |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Haloperidol 2 mg oral tablet |
Has precise active ingredient |
True |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely haloperidol 5 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Haloperidol 10 mg oral tablet |
Has precise active ingredient |
True |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Haloperidol 20 mg oral tablet |
Has precise active ingredient |
True |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Haloperidol 1 mg oral tablet |
Has precise active ingredient |
True |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Haloperidol 1.5 mg oral tablet |
Has precise active ingredient |
True |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Haloperidol 1 mg/mL oral solution |
Has precise active ingredient |
True |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Haloperidol 1 mg/mL oral solution |
Has basis of strength substance (attribute) |
True |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely haloperidol 2 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has basis of strength substance (attribute) |
True |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely haloperidol 2 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has precise active ingredient |
True |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely haloperidol (as haloperidol decanoate) 100 milligram/1 milliliter prolonged-release oil for injection ampule |
Has basis of strength substance (attribute) |
False |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely haloperidol 20 milligram/2 milliliter conventional release solution for injection ampule |
Has basis of strength substance (attribute) |
False |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely haloperidol 20 milligram/2 milliliter conventional release solution for injection ampule |
Has precise active ingredient |
False |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely haloperidol (as haloperidol decanoate) 50 milligram/1 milliliter prolonged-release oil for injection ampule |
Has basis of strength substance (attribute) |
False |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely haloperidol 5 milligram/1 milliliter conventional release solution for injection ampule |
Has basis of strength substance (attribute) |
False |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely haloperidol 5 milligram/1 milliliter conventional release solution for injection ampule |
Has precise active ingredient |
False |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only haloperidol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only haloperidol in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only haloperidol in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Haloperidol 10 mg/mL solution for injection |
Has basis of strength substance (attribute) |
True |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Haloperidol 10 mg/mL solution for injection |
Has precise active ingredient |
True |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely haloperidol 5 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has precise active ingredient |
True |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely haloperidol 5 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely haloperidol (as haloperidol decanoate) 50 milligram/1 milliliter prolonged-release oil for injection (clinical drug) |
Has basis of strength substance (attribute) |
False |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely haloperidol (as haloperidol decanoate) 100 milligram/1 milliliter prolonged-release oil for injection (clinical drug) |
Has basis of strength substance (attribute) |
False |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Haloperidol 300 microgram/mL oral solution |
Has basis of strength substance (attribute) |
True |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Haloperidol 300 microgram/mL oral solution |
Has precise active ingredient |
True |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Haloperidol 200 microgram/mL oral solution |
Has basis of strength substance (attribute) |
True |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Haloperidol 200 microgram/mL oral solution |
Has precise active ingredient |
True |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely haloperidol 400 microgram/1 milliliter conventional release oral solution (clinical drug) |
Has precise active ingredient |
True |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely haloperidol 400 microgram/1 milliliter conventional release oral solution (clinical drug) |
Has basis of strength substance (attribute) |
True |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Haloperidol (as haloperidol decanoate) 100 mg/mL solution for injection |
Has basis of strength substance (attribute) |
True |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Haloperidol (as haloperidol decanoate) 50 mg/mL solution for injection |
Has basis of strength substance (attribute) |
True |
Haloperidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.4-SNAPSHOT
|
FHIR Version n/a
User: [n/a]